Published in Thromb Haemost on April 30, 1981
Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact? Nat Rev Cardiol (2009) 0.94
Platelet function tests: why they fail to guide personalized antithrombotic medication. J Am Heart Assoc (2015) 0.81
Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man. Br J Clin Pharmacol (1987) 0.77
Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet (1967) 5.38
The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest (1968) 3.66
Effects of 5-hydroxytryptamine on platelet aggregation. Nature (1968) 3.08
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest (1973) 2.94
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest (1973) 2.71
Rheological aspects of thrombosis and haemostasis: basic principles and applications. ICTH-Report--Subcommittee on Rheology of the International Committee on Thrombosis and Haemostasis. Thromb Haemost (1986) 2.54
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (1989) 2.46
Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med (1974) 2.44
Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med (1975) 2.31
Homeless persons and health care. Ann Intern Med (1986) 2.22
Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res (1978) 2.14
Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med (1974) 1.86
Transient arthritis after rubella vaccination. Am J Dis Child (1969) 1.86
The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets. J Physiol (1969) 1.85
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest (1977) 1.85
Computer modeling of intracranial saccular and lateral aneurysms for the study of their hemodynamics. Neurosurgery (1995) 1.82
Filling gaps in the vascular endothelium with blood platelets. Nature (1967) 1.69
Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med (1975) 1.69
Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem (1989) 1.63
Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography. Thromb Diath Haemorrh (1972) 1.61
An electron microscopic study of platelet thrombus formation in the rabbit with particular regard to 5-hydroxytryptamine release. Thromb Diath Haemorrh (1967) 1.61
5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets. J Physiol (1969) 1.57
The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res (1973) 1.57
Molecular forms of antihaemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol (1970) 1.57
Secretable storage pools in platelets. Annu Rev Med (1979) 1.49
Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity. Science (1973) 1.49
The subendothelial microfibril and platelet adhesion. Lab Invest (1971) 1.48
Aspirin--a dangerous drug? JAMA (1974) 1.47
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med (1978) 1.46
Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med (1971) 1.46
Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood (1978) 1.39
Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38
Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelets with alpha chymotrypsin-digested subendothelium. Thromb Haemost (1977) 1.34
Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood (1979) 1.33
Blood viscosity, mass transport, and thrombogenesis. Prog Hemost Thromb (1982) 1.33
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest (1989) 1.33
Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J Chronic Dis (1977) 1.31
Adhesion of platelets to subendothelium. Ann N Y Acad Sci (1972) 1.29
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med (1982) 1.26
Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate. Am J Med (1972) 1.25
Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function. Thromb Haemost (1976) 1.24
Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia. J Lab Clin Med (1968) 1.24
Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol (1970) 1.23
Adhesion of blood platelets to subendothelial surface: distinct from adhesion to collagen. Experientia (1971) 1.23
Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia--"storage pool disease". Blood (1972) 1.23
Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood (1986) 1.21
Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest (1984) 1.20
[Effects of vascular catheterization in normo- and hypercholesteremic rabbits]. Pathol Microbiol (Basel) (1966) 1.20
A familialdefect in platelet function associated with imapired release of adenosine diphosphate. N Engl J Med (1969) 1.18
Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease. J Lab Clin Med (1979) 1.17
A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease. Prostaglandins (1973) 1.17
Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency). A comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med (1967) 1.16
Significance of fixation procedure for preservation of arteries. Experientia (1972) 1.16
Isolated deficiency of platelet procoagulant activity. Am J Med (1979) 1.15
Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. Microvasc Res (1975) 1.15
Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Br J Haematol (1980) 1.14
Red blood cells: their dual role in thrombus formation. Science (1980) 1.13
Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest (1986) 1.13
Thrombocytopathia due to abnormalities in platelet release reaction--studies on six unrelated patients. Blood (1972) 1.12
Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate. Microvasc Res (1979) 1.09
Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemost (1981) 1.07
Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest (1994) 1.07
Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. Arteriosclerosis (1990) 1.06
Editorial: Platelet function tests and their interpretation. J Lab Clin Med (1976) 1.06
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med (1983) 1.06
Von Willebrand's disease--diagnostic criteria. Blood (1968) 1.06
Flow as a regulator of the activation of factor X by tissue factor. Blood (1988) 1.05
Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood (1985) 1.05
Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension (1991) 1.04
Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism. J Clin Invest (1974) 1.03
Antiplatelet therapy (first of two parts). N Engl J Med (1978) 1.02
Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor. Blood (1992) 1.02